Literature DB >> 1639346

Bile-duct destruction and collagen deposition: a prominent ultrastructural feature of the liver in cystic fibrosis.

A Lindblad1, R Hultcrantz, B Strandvik.   

Abstract

To study the liver disease of patients with cystic fibrosis, percutaneous liver biopsies were performed in 10 patients with cystic fibrosis aged 6 to 22 yr. Nine of 10 patients had high Shwachman scores, eight had normal serum levels of transaminases. Light-microscopical examination showed steatosis in seven cases and in five slight or moderate inflammatory infiltration. Eight patients showed varying degrees of fibrosis and even cirrhosis. Six patients had bile-duct proliferation and, in one case a bile plug was found. Other signs of cholestasis were not seen. Electron-microscopical investigation showed no specific signs of cholestasis such as ductal plugs or intracellular bile pigments. The canaliculi were not dilated, except in one case. Most patients had bile-duct cells with irregular shapes, protruding into the lumen, and some cases even had necrotic cells. Around the bile ducts and ductules, collagen was deposited and fat-storing cells were a common finding. Our findings do not support the view that cholestasis is the pathogenetic factor in liver disease in cystic fibrosis. A cytotoxic influence on the biliary cells, stimulating collagen deposition, seems more likely.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639346     DOI: 10.1002/hep.1840160215

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  12 in total

1.  Hepatolithiasis and cholangiocarcinoma in cystic fibrosis: a case series and review of the literature.

Authors:  David G Perdue; Oliver W Cass; Carlos Milla; Jordan Dunitz; Jose Jessurun; Harvey L Sharp; Sarah J Schwarzenberg
Journal:  Dig Dis Sci       Date:  2007-04-19       Impact factor: 3.199

Review 2.  Liver disease in cystic fibrosis.

Authors:  M S Tanner; C J Taylor
Journal:  Arch Dis Child       Date:  1995-04       Impact factor: 3.791

Review 3.  Liver transplantation for hepatic cirrhosis in cystic fibrosis.

Authors:  G Noble-Jamieson; N Barnes; N Jamieson; P Friend; R Calne
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

4.  Low linoleic and high docosahexaenoic acids in a severe phenotype of transgenic cystic fibrosis mice.

Authors:  Birgitta Strandvik; Wanda K O Neal; Mohamed A Ali; Ulf Hammar
Journal:  Exp Biol Med (Maywood)       Date:  2018-03

5.  The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease.

Authors:  Peter J Lewindon; Tamara N Pereira; Anita C Hoskins; Kim R Bridle; Richard M Williamson; Ross W Shepherd; Grant A Ramm
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 6.  The gallbladder and biliary tract in cystic fibrosis.

Authors:  Michael P Curry; John E Hegarty
Journal:  Curr Gastroenterol Rep       Date:  2005-05

Review 7.  Cystic fibrosis from the gastroenterologist's perspective.

Authors:  Chee Y Ooi; Peter R Durie
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-01-21       Impact factor: 46.802

Review 8.  Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota.

Authors:  Romina Fiorotto; Mario Strazzabosco
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-05-07

9.  Liver X receptor β regulates bile volume and the expression of aquaporins and cystic fibrosis transmembrane conductance regulator in the gallbladder.

Authors:  Nathan Sweed; Hyun-Jin Kim; Kjell Hultenby; Rodrigo Barros; Paoo Parini; Valentina Sancisi; Birgitta Strandvik; Chiara Gabbi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-07-14       Impact factor: 4.871

Review 10.  Transport systems in cholangiocytes: their role in bile formation and cholestasis.

Authors:  M Strazzabosco
Journal:  Yale J Biol Med       Date:  1997 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.